[Massive transfusion in cancer surgery. A study of the survival of 21 patients].
In a retrospective study over 5 years, the evolution of 21 patients who received a massive blood transfusion during a carcinological surgery was analyzed. In this type of surgery, the frequency of massive blood transfusion is 0.28% and affects 2.5% of the patients transfused. In half of the cases, surgery was performed to resect an ovarian cancer. The overall death rate, related to the importance of the blood transfusion, is high: 38% (8 patients out of 21). Among the patients who survived (13), the actuarial survival is low: 10 deaths from local or metastatic disease with a mean survival of 12 months, suggesting that the use of massive blood transfusion was related to the tumoral aggressiveness and to the severity of the deepseated malignant disease.
Montange
F
F
Centr Alexis-Vautrin, Vandoeuvre-les-Nancy.
Salm
B
B
Godfrin
P Y
PY
Dartois
D
D
Carolus
J
J
D000206:Actuarial Analysis; D016063:Blood Loss, Surgical; D001803:Blood Transfusion / Q000379:methods / Q000401:mortality; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000601:surgery*; D010051:Ovarian Neoplasms / Q000601:surgery; D011379:Prognosis; D012189:Retrospective Studies; D016019:Survival Analysis; D065227:Transfusion Reaction
Transfusions massives en chirurgie carcinologique. Etude de la survie de 21 malades.